Project Details
Description
A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects with Phenylketonuria (PKU ASCEND)
Status | Finished |
---|---|
Effective start/end date | 4/23/12 → 6/23/13 |
Funding
- BIOMARIN PHARMACEUTICAL, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.